Telemedicine is a medical activity in which a medical institution or patient invites other medical institutions to provide technical support for the diagnosis and treatment of patients using communication, computer and network technologies. Telemedicine services include remote clinics, remote pathology diagnostics, telemedicine imaging diagnostics, telemonitoring, teleconsultation, and remote case discussions.
The development of domestic medical informatization started after SARS in 2003. After the new medical reform in 2009, the in-house information construction and regional medical information platform were gradually strengthened. The telemedicine between hospitals and hospitals continued to mature. After 2014, with the popularization of mobile medical terminals, The development of medical Internet of Things and the increased participation of medical institutions have gradually begun to explore the telemedicine business model for individuals. It is expected to bring rapid development of telemedicine after 2015.
Telemedicine can provide patients with better medical services and better cost-effective services, improve the accessibility of medical resources, medical quality, and medical cost performance. Telemedicine saves the cost of medical treatment for patients in remote areas, improves the scarcity and uneven distribution of medical care in remote areas, strengthens the ability of emergency services, reduces waiting time for patients in remote areas and urban areas through online consultation, and realizes effective self-management of chronic diseases. Reduce the number of hospitalizations and emergency visits, and guide more patients to the community to seek medical treatment to reduce overall medical costs.
In Ontario, Canada, for example, the 2013 remote clinical video consultation saved 260 million kilometers of travel for patients; it saved 146 million kilometers of travel for patients in northern Ontario, saving $61.8 million. A survey of patients receiving remote clinical video consultations showed that 92% of patients were satisfied with telemedicine services, 91% said they would continue to use telemedicine services, and 87% thought telemedicine and doctors face-to-face clinics, remote clinical video consultations Save an average of $242 for each patient.
In China, the market size of telemedicine (including remote patient monitoring, video conferencing, online consultation, personal medical care devices, wireless access to electronic cases and prescriptions) reached 2.21 billion yuan in 2013, an increase of 20.8% over the previous year. The market size will reach 9.58 billion yuan, including the rapid development of mobile medical terminals, the development of medical Internet of Things, and the increased participation of medical institutions.
Ping An Securities believes that the scale of China's telemedicine market reached 2.21 billion yuan in 2013, a year-on-year increase of 20.8%. It is expected to reach 9.58 billion yuan by the end of 2017. With the popularization of mobile medical terminals, the development of medical Internet of Things, and the increased participation of medical institutions, telemedicine will develop rapidly in 2015. The current problem of expensive medical treatment has spawned a huge demand for the development of medical treatment by means of telemedicine. In addition, the state has intensively introduced various policies to encourage the exploration of a telemedicine service platform based on the regional population health information platform. In terms of technology, the development of medical wearable devices, medical smart apps, 4g transmission networks, cloud computing and big data is driving the rapid development of telemedicine.
Jiu'an Medical: Introducing Xiaomi Investment, increasing the expansion of mobile medical care, and sailing will surely sail!
The company's new entity, ihealthinc, will introduce Xiaomi's investment of US$25 million in strategic investment, and ihealth will become a partner in Xiaomi's mobile health field. 2. The company's announcement is no less than 18.40 yuan / share, through non-public issuance of no more than 44 million shares, raised no more than 810 million yuan, mainly used for investment in mobile medical peripheral ecological and intelligent hardware research and development base.
1. Introduce Xiaomi Investment into a big hand, and build a mobile health cloud platform with Internet thinking! (1) Leverage Xiaomi to develop the domestic market. The company established its grand company ihealthinc in Cayman. Introducing Xiaomi's investment of 25 million US dollars as a strategic investor, Xiaomi Investment will hold 20% of the new company's shares. Since then, Xiaomi will cooperate with ihealth in user experience, Xiaomi e-commerce and cloud services to jointly build a mobile health cloud platform. We believe that ihealth has proven to have strong competitive advantages and market acceptance in North America and other overseas markets (2013 revenues of 10 million US dollars, in the first half of 2014, only 2 million euros in the European market), after the introduction of Xiaomi, will Fully leverage the advantages of Xiaomi in Internet thinking operations, e-commerce channels, user experience, etc., and further expand market share in China, and seize the opportunity to acquire users (previously the company has launched the ihealth sphygmomanometer in Jingdong cooperation). (2) Incentives are in place, Xiaomi invests 20% of the company's total share capital; 10% of the total share capital is used as treasury stocks for future employee equity incentives, and 70% of the equity is held by Jiu'an Medical, which will introduce talents for the future. Make a foundation. (3) Exclusive commitment to fully guarantee the quality of cooperation. Xiaomi Investment and its related parties undertake not to invest in projects or companies with the following products as their main business scope (“Company Competitorsâ€) within two years after the completion of the project: a. Medical platform, product based on healthy big data or; b. Blood pressure and blood glucose measurement products are measured as single function blood pressure and blood glucose measurement products. We believe that the next two years will be the outbreak of Internet medical care. Xiaomi's commitment fully demonstrates the determination to cooperate with ihealth and great confidence, which will help the two sides to cooperate with each other.
Frozen Mussels,Frozen Cooked Clean Mussel Meat,Cooked Mussel Meat,Seafood Mussel Meat
Shengsi Huali Aquatic Products Co.,Ltd , https://www.mytilus-edulis.com